Prevent Cancer Dialogue: Minimal Residual Disease (MRD): Exploring the impact on cancer early detection and personalized care

In this session, speakers will delve into the cutting-edge science of Minimal Residual Disease (MRD) testing, a revolutionary approach to cancer detection. We’ll explore how these tests can help determine prognosis/relapse risk, find early recurrence and individualize treatment to improve patient outcomes. 

Register here.